Perbedaan Midi Utama Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Midi Utama Indonesia Tbk. diperdagangkan di Rp282 (kapitalisasi pasar 9,5 T, volume 24 jam 1,62 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Midi Utama Indonesia Tbk. jauh lebih besar — sekitar 56,8× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Midi Utama Indonesia Tbk. lebih aktif diperdagangkan (1,62 jt vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MIDI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 9,5 T | 167,37 M |
Volume | 1,62 jt | 96,7 rb |
Lot | 16,19 rb | 967 |
Perputaran | 454,66 jt | 23,82 jt |
Harga Rata-rata | 280,76 | 246,34 |
Nilai Transaksi | 454,66 jt | 23,82 jt |
Harga Ekuilibrium Indikatif | 282 | 248 |
Volume Ekuilibrium Indikatif | 803 | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Selengkapnya di halaman MIDI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →